カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のFDA用減量デバイス市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global FDA Grade Weight-Loss Devices Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	■ 発行会社/調査会社：GlobalInfoResearch ■ 商品コード：GIR22MY7885 ■ 発行日：2022年5月（※2025年版があります。お問い合わせください。） ■ 調査対象地域：グローバル ■ 産業分野：医療機器 ■ ページ数：113 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール（注文後2-3日）

■ 販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界のFDA用減量デバイス市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら

*** レポート概要（サマリー）***

FDA用減量デバイス市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のFDA用減量デバイスの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

FDA用減量デバイス市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・胃バンド、電気刺激システム、胃バルーンシステム、胃排出システム、その他

用途別セグメントは次のように区分されます。
・病院、クリニック、家庭、その他

世界のFDA用減量デバイス市場の主要な市場プレーヤーは以下のとおりです。
・ReShape Medical、Helioscopie Medical Implants、Allurion、Spatz FGIA、Lexal、Obalon、Medsil、Endalis、Districlass Medical、Medicone、Silimed、Ethicon、Millennium Surgical、MID (Medical Innovation Developpement)、Apollo Endosurgery、Cousin Biotech

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、FDA用減量デバイス製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なFDA用減量デバイスメーカーの企業概要、2019年～2022年までのFDA用減量デバイスの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なFDA用減量デバイスメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別FDA用減量デバイスの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのFDA用減量デバイスの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのFDA用減量デバイス市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびFDA用減量デバイスの産業チェーンを掲載しています。
・第13、14、15章では、FDA用減量デバイスの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：ReShape Medical、Helioscopie Medical Implants、Allurion、Spatz FGIA、Lexal、Obalon、Medsil、Endalis、Districlass Medical、Medicone、Silimed、Ethicon、Millennium Surgical、MID (Medical Innovation Developpement)、Apollo Endosurgery、Cousin Biotech
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：胃バンド、電気刺激システム、胃バルーンシステム、胃排出システム、その他
・用途別分析2017年-2028年：病院、クリニック、家庭、その他
・FDA用減量デバイスの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・FDA用減量デバイスのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・FDA用減量デバイスのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・FDA用減量デバイスの南米市場規模2017年-2028年：ブラジル、アルゼンチン
・FDA用減量デバイスの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The FDA Grade Weight-Loss Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global FDA Grade Weight-Loss Devices market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the FDA Grade Weight-Loss Devices global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Gastric Band segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of FDA Grade Weight-Loss Devices include ReShape Medical, Helioscopie Medical Implants, Allurion, Spatz FGIA, and Lexal, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
FDA Grade Weight-Loss Devices market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Gastric Band
Electrical Stimulation Systems
Gastric Balloon Systems
Gastric Emptying Systems
Others
Market segment by Application can be divided into
Hospital
Clinic
Household
Others
The key market players for global FDA Grade Weight-Loss Devices market are listed below:
ReShape Medical
Helioscopie Medical Implants
Allurion
Spatz FGIA
Lexal
Obalon
Medsil
Endalis
Districlass Medical
Medicone
Silimed
Ethicon
Millennium Surgical
MID (Medical Innovation Developpement)
Apollo Endosurgery
Cousin Biotech
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe FDA Grade Weight-Loss Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of FDA Grade Weight-Loss Devices, with price, sales, revenue and global market share of FDA Grade Weight-Loss Devices from 2019 to 2022.
Chapter 3, the FDA Grade Weight-Loss Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the FDA Grade Weight-Loss Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and FDA Grade Weight-Loss Devices market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of FDA Grade Weight-Loss Devices.
Chapter 13, 14, and 15, to describe FDA Grade Weight-Loss Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 FDA Grade Weight-Loss Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global FDA Grade Weight-Loss Devices Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Gastric Band
1.2.3 Electrical Stimulation Systems
1.2.4 Gastric Balloon Systems
1.2.5 Gastric Emptying Systems
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global FDA Grade Weight-Loss Devices Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.3.5 Others
1.4 Global FDA Grade Weight-Loss Devices Market Size & Forecast
1.4.1 Global FDA Grade Weight-Loss Devices Sales in Value (2017 & 2021 & 2028)
1.4.2 Global FDA Grade Weight-Loss Devices Sales in Volume (2017-2028)
1.4.3 Global FDA Grade Weight-Loss Devices Price (2017-2028)
1.5 Global FDA Grade Weight-Loss Devices Production Capacity Analysis
1.5.1 Global FDA Grade Weight-Loss Devices Total Production Capacity (2017-2028)
1.5.2 Global FDA Grade Weight-Loss Devices Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 FDA Grade Weight-Loss Devices Market Drivers
1.6.2 FDA Grade Weight-Loss Devices Market Restraints
1.6.3 FDA Grade Weight-Loss Devices Trends Analysis
2 Manufacturers Profiles
2.1 ReShape Medical
2.1.1 ReShape Medical Details
2.1.2 ReShape Medical Major Business
2.1.3 ReShape Medical FDA Grade Weight-Loss Devices Product and Services
2.1.4 ReShape Medical FDA Grade Weight-Loss Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Helioscopie Medical Implants
2.2.1 Helioscopie Medical Implants Details
2.2.2 Helioscopie Medical Implants Major Business
2.2.3 Helioscopie Medical Implants FDA Grade Weight-Loss Devices Product and Services
2.2.4 Helioscopie Medical Implants FDA Grade Weight-Loss Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Allurion
2.3.1 Allurion Details
2.3.2 Allurion Major Business
2.3.3 Allurion FDA Grade Weight-Loss Devices Product and Services
2.3.4 Allurion FDA Grade Weight-Loss Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Spatz FGIA
2.4.1 Spatz FGIA Details
2.4.2 Spatz FGIA Major Business
2.4.3 Spatz FGIA FDA Grade Weight-Loss Devices Product and Services
2.4.4 Spatz FGIA FDA Grade Weight-Loss Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Lexal
2.5.1 Lexal Details
2.5.2 Lexal Major Business
2.5.3 Lexal FDA Grade Weight-Loss Devices Product and Services
2.5.4 Lexal FDA Grade Weight-Loss Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Obalon
2.6.1 Obalon Details
2.6.2 Obalon Major Business
2.6.3 Obalon FDA Grade Weight-Loss Devices Product and Services
2.6.4 Obalon FDA Grade Weight-Loss Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Medsil
2.7.1 Medsil Details
2.7.2 Medsil Major Business
2.7.3 Medsil FDA Grade Weight-Loss Devices Product and Services
2.7.4 Medsil FDA Grade Weight-Loss Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Endalis
2.8.1 Endalis Details
2.8.2 Endalis Major Business
2.8.3 Endalis FDA Grade Weight-Loss Devices Product and Services
2.8.4 Endalis FDA Grade Weight-Loss Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Districlass Medical
2.9.1 Districlass Medical Details
2.9.2 Districlass Medical Major Business
2.9.3 Districlass Medical FDA Grade Weight-Loss Devices Product and Services
2.9.4 Districlass Medical FDA Grade Weight-Loss Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Medicone
2.10.1 Medicone Details
2.10.2 Medicone Major Business
2.10.3 Medicone FDA Grade Weight-Loss Devices Product and Services
2.10.4 Medicone FDA Grade Weight-Loss Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Silimed
2.11.1 Silimed Details
2.11.2 Silimed Major Business
2.11.3 Silimed FDA Grade Weight-Loss Devices Product and Services
2.11.4 Silimed FDA Grade Weight-Loss Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Ethicon
2.12.1 Ethicon Details
2.12.2 Ethicon Major Business
2.12.3 Ethicon FDA Grade Weight-Loss Devices Product and Services
2.12.4 Ethicon FDA Grade Weight-Loss Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Millennium Surgical
2.13.1 Millennium Surgical Details
2.13.2 Millennium Surgical Major Business
2.13.3 Millennium Surgical FDA Grade Weight-Loss Devices Product and Services
2.13.4 Millennium Surgical FDA Grade Weight-Loss Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 MID (Medical Innovation Developpement)
2.14.1 MID (Medical Innovation Developpement) Details
2.14.2 MID (Medical Innovation Developpement) Major Business
2.14.3 MID (Medical Innovation Developpement) FDA Grade Weight-Loss Devices Product and Services
2.14.4 MID (Medical Innovation Developpement) FDA Grade Weight-Loss Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Apollo Endosurgery
2.15.1 Apollo Endosurgery Details
2.15.2 Apollo Endosurgery Major Business
2.15.3 Apollo Endosurgery FDA Grade Weight-Loss Devices Product and Services
2.15.4 Apollo Endosurgery FDA Grade Weight-Loss Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Cousin Biotech
2.16.1 Cousin Biotech Details
2.16.2 Cousin Biotech Major Business
2.16.3 Cousin Biotech FDA Grade Weight-Loss Devices Product and Services
2.16.4 Cousin Biotech FDA Grade Weight-Loss Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 FDA Grade Weight-Loss Devices Breakdown Data by Manufacturer
3.1 Global FDA Grade Weight-Loss Devices Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global FDA Grade Weight-Loss Devices Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in FDA Grade Weight-Loss Devices
3.4 Market Concentration Rate
3.4.1 Top 3 FDA Grade Weight-Loss Devices Manufacturer Market Share in 2021
3.4.2 Top 6 FDA Grade Weight-Loss Devices Manufacturer Market Share in 2021
3.5 Global FDA Grade Weight-Loss Devices Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and FDA Grade Weight-Loss Devices Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global FDA Grade Weight-Loss Devices Market Size by Region
4.1.1 Global FDA Grade Weight-Loss Devices Sales in Volume by Region (2017-2028)
4.1.2 Global FDA Grade Weight-Loss Devices Revenue by Region (2017-2028)
4.2 North America FDA Grade Weight-Loss Devices Revenue (2017-2028)
4.3 Europe FDA Grade Weight-Loss Devices Revenue (2017-2028)
4.4 Asia-Pacific FDA Grade Weight-Loss Devices Revenue (2017-2028)
4.5 South America FDA Grade Weight-Loss Devices Revenue (2017-2028)
4.6 Middle East and Africa FDA Grade Weight-Loss Devices Revenue (2017-2028)
5 Market Segment by Type
5.1 Global FDA Grade Weight-Loss Devices Sales in Volume by Type (2017-2028)
5.2 Global FDA Grade Weight-Loss Devices Revenue by Type (2017-2028)
5.3 Global FDA Grade Weight-Loss Devices Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global FDA Grade Weight-Loss Devices Sales in Volume by Application (2017-2028)
6.2 Global FDA Grade Weight-Loss Devices Revenue by Application (2017-2028)
6.3 Global FDA Grade Weight-Loss Devices Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America FDA Grade Weight-Loss Devices Sales by Type (2017-2028)
7.2 North America FDA Grade Weight-Loss Devices Sales by Application (2017-2028)
7.3 North America FDA Grade Weight-Loss Devices Market Size by Country
7.3.1 North America FDA Grade Weight-Loss Devices Sales in Volume by Country (2017-2028)
7.3.2 North America FDA Grade Weight-Loss Devices Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe FDA Grade Weight-Loss Devices Sales by Type (2017-2028)
8.2 Europe FDA Grade Weight-Loss Devices Sales by Application (2017-2028)
8.3 Europe FDA Grade Weight-Loss Devices Market Size by Country
8.3.1 Europe FDA Grade Weight-Loss Devices Sales in Volume by Country (2017-2028)
8.3.2 Europe FDA Grade Weight-Loss Devices Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific FDA Grade Weight-Loss Devices Sales by Type (2017-2028)
9.2 Asia-Pacific FDA Grade Weight-Loss Devices Sales by Application (2017-2028)
9.3 Asia-Pacific FDA Grade Weight-Loss Devices Market Size by Region
9.3.1 Asia-Pacific FDA Grade Weight-Loss Devices Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific FDA Grade Weight-Loss Devices Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America FDA Grade Weight-Loss Devices Sales by Type (2017-2028)
10.2 South America FDA Grade Weight-Loss Devices Sales by Application (2017-2028)
10.3 South America FDA Grade Weight-Loss Devices Market Size by Country
10.3.1 South America FDA Grade Weight-Loss Devices Sales in Volume by Country (2017-2028)
10.3.2 South America FDA Grade Weight-Loss Devices Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa FDA Grade Weight-Loss Devices Sales by Type (2017-2028)
11.2 Middle East & Africa FDA Grade Weight-Loss Devices Sales by Application (2017-2028)
11.3 Middle East & Africa FDA Grade Weight-Loss Devices Market Size by Country
11.3.1 Middle East & Africa FDA Grade Weight-Loss Devices Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa FDA Grade Weight-Loss Devices Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of FDA Grade Weight-Loss Devices and Key Manufacturers
12.2 Manufacturing Costs Percentage of FDA Grade Weight-Loss Devices
12.3 FDA Grade Weight-Loss Devices Production Process
12.4 FDA Grade Weight-Loss Devices Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 FDA Grade Weight-Loss Devices Typical Distributors
13.3 FDA Grade Weight-Loss Devices Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

H&I Global Research

世界のFDA用減量デバイス市場2022年：市場規模予測（～2028年）

グローバル市場調査会社